RT Journal Article
SR Electronic
T1 Screening for urologic malignancies in primary care: Pros, cons, and recommendations
JF Cleveland Clinic Journal of Medicine
JO Cleve Clin J Med
FD Cleveland Clinic
SP S6
OP S14
VO 74
IS 5 suppl 3
A1 Rosenberg, Matt T.
A1 Lakin, Milton M.
A1 Staskin, David R.
A1 Stephenson, Andrew J.
A1 Kuritzky, Louis
A1 Campbell, Steven C.
YR 2007
UL http://www.ccjm.org/content/74/5_suppl_3/S6.abstract
AB Interest in screening for urologic cancers has grown in recent years. This article considers the pros and cons of screening for four epidemiologically compelling urologic cancers: prostate, bladder, kidney, and testicular. Unfortunately, many of the urologic cancers do not meet the criteria for a successful cancer screening programnamely, high prevalence, availability of a sensitive and specific screening test, ability to detect clinically important cancers at an early stage, and cost-effectiveness. While age-based screening for prostate cancer should be offered to the general population after discussion of its benefits and risks, for the other three urologic malignancies the current consensus points more toward selective screening based on specific patient risk factors.